CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN), a leader in life science research, today announced the release of ChargeSwitch®-Pro Plasmid Miniprep kits. The kits apply ChargeSwitch® Technology, the latest generation in nucleic acid purification chemistry, into the popular spin column format. This development represents the third format available for the ChargeSwitch® Technology platform and further extends the available handling options.
